Princeton Global Asset Management LLC Sorrento Therapeutics, Inc. Transaction History

Princeton Global Asset Management LLC

  • $397 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 08, 2021
BUY
$7.41 - $10.99 $852 - $1,263
115 Added 11500.0%
116 $1,000
Q3 2021

Nov 03, 2021
SELL
$7.41 - $10.99 $852 - $1,263
-115 Reduced 99.14%
1 $1,000
Q2 2020

Aug 11, 2020
BUY
$1.73 - $6.76 $200 - $784
116 New
116 $0

Others Institutions Holding SRNE

# of Institutions
15
Shares Held
5.51M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Princeton Global Asset Management LLC Portfolio

Follow Princeton Global Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Princeton Global Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Princeton Global Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email